GO:1904635 positive regulation of podocyte apoptotic process: Apoptosis Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904635 describes any process that activates or increases the frequency, rate or extent of glomerular visceral epithelial cell (podocyte) apoptosis.
• Podocyte apoptosis is a key driver of glomerular disease progression, including diabetic nephropathy, lupus nephritis, and focal segmental glomerulosclerosis.
• Soluble RARRES1 is a secreted factor that directly induces podocyte apoptosis and promotes glomerular disease progression.
• Mitochondrial fission mediated by Drp1 and ROCK signaling are critical positive regulators of podocyte apoptosis.
• MicroRNA-21 and Semaphorin3A are additional regulators that influence podocyte survival and apoptotic pathways.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of genes that positively regulate podocyte apoptosis.
Description
GO:1904635, positive regulation of podocyte apoptotic process, is a Gene Ontology biological process term that encompasses any molecular event that activates or increases the frequency, rate, or extent of apoptosis in glomerular visceral epithelial cells, commonly known as podocytes. Podocytes are terminally differentiated epithelial cells that form the outer layer of the glomerular filtration barrier, and their loss through apoptosis is a hallmark of progressive kidney diseases. Understanding the positive regulators of podocyte apoptosis is therefore central to nephrology research and therapeutic development. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the term, its mechanisms, key genes, disease relevance, and experimental methods for investigation.
positive regulation of podocyte apoptotic process At A Glance
| GO ID | GO:1904635 |
|---|---|
| GO term | positive regulation of podocyte apoptotic process |
| Ontology | biological_process |
| Synonym | activation of podocyte apoptosis; upregulation of glomerular visceral epithelial cell apoptotic process; positive regulation of glomerular podocyte apoptosis |
| Major function | Promotion of programmed cell death in glomerular visceral epithelial cells (podocytes) |
| Related cellular component | Glomerular filtration barrier; podocyte foot processes; slit diaphragm |
| Related molecular functions | Caspase activation; mitochondrial fission; kinase signaling (e.g., ROCK, Drp1) |
| Disease relevance | Diabetic nephropathy, lupus nephritis, focal segmental glomerulosclerosis, glomerular disease progression |
What Is GO:1904635?
GO:1904635 is defined by QuickGO as any process that activates or increases the frequency, rate or extent of glomerular visceral epithelial cell apoptotic process. In simpler terms, it covers all signaling events, molecular interactions, and cellular changes that promote the programmed cell death of podocytes. This includes both direct activation of apoptotic machinery and indirect sensitization of podocytes to apoptotic stimuli.
Why Is positive regulation of podocyte apoptotic process Important in Cell Biology?
Podocyte apoptosis is an irreversible event that leads to podocyte depletion, proteinuria, and glomerulosclerosis. Positive regulators of this process are therefore attractive therapeutic targets: inhibiting them may preserve podocyte number and slow chronic kidney disease progression. Conversely, understanding these regulators is essential for deciphering the molecular pathogenesis of diabetic nephropathy, lupus nephritis, and other glomerular disorders.
• Podocyte apoptosis is a final common pathway in many progressive kidney diseases.
• Positive regulators such as RARRES1 and Drp1 are potential drug targets for nephroprotection.
• MicroRNA-21 modulates podocyte injury and apoptosis, linking epigenetic regulation to glomerular disease.
• Semaphorin3A inhibition reduces doxorubicin-induced podocyte injury, highlighting apoptotic signaling as a therapeutic node.
• ROCK signaling promotes podocyte apoptosis and is a target in non-malignant and malignant diseases.
• IRF2 signaling networks facilitate podocyte pyroptosis in lupus nephritis, a related inflammatory cell death pathway.
• Cell cycle dysregulation in podocytes contributes to glomerular disease, intersecting with apoptotic pathways.
• Huperzine A targeting Apolipoprotein E may protect podocytes in diabetic nephropathy, linking apoptosis to metabolic regulation.
• Berberine protects podocytes by inhibiting Drp1-mediated mitochondrial fission, directly opposing positive regulation of apoptosis.
• CRISPR screens can identify novel positive regulators of podocyte apoptosis for therapeutic discovery.
What Happens During positive regulation of podocyte apoptotic process?
Initiation by Death Ligands and Secreted Factors
In simple terms: External signals tell podocytes to begin the self-destruction process.
Positive regulation of podocyte apoptosis can be initiated by secreted factors such as soluble RARRES1, which directly induces podocyte apoptosis and promotes glomerular disease progression. Other extracellular cues, including Semaphorin3A, can sensitize podocytes to apoptotic stimuli. These ligands engage surface receptors and trigger intracellular signaling cascades that commit the cell to apoptosis.
Mitochondrial Fission and Dysfunction
In simple terms: The cell's power plants fragment and fail, pushing the cell toward death.
Drp1-mediated mitochondrial fission is a key step in podocyte apoptosis. Berberine protects podocytes by inhibiting Drp1-mediated mitochondrial fission and dysfunction, demonstrating that mitochondrial dynamics are causally linked to positive regulation of apoptosis. Mitochondrial outer membrane permeabilization releases pro-apoptotic factors that activate caspases.
Caspase Activation and Apoptosome Formation
In simple terms: A molecular executioner team is assembled to dismantle the cell.
Following mitochondrial dysfunction, cytochrome c release leads to apoptosome formation and activation of executioner caspases. While specific caspase cascades in podocytes are not fully detailed in the provided citations, the general apoptotic machinery is conserved. RARRES1-induced apoptosis likely converges on caspase activation.
Cytoskeletal Rearrangement and ROCK Signaling
In simple terms: The cell's internal skeleton is dismantled, changing its shape and function.
ROCK signaling is a positive regulator of apoptosis in various cell types, including podocytes. ROCK activation promotes actomyosin contraction, membrane blebbing, and apoptotic body formation. Targeting ROCK signaling has therapeutic potential in glomerular diseases.
Inflammatory and Pyroptotic Crosstalk
In simple terms: Inflammatory cell death pathways can also promote podocyte loss.
IRF2 signaling networks facilitate podocyte pyroptosis in lupus nephritis, a process related to apoptosis. This suggests that positive regulation of podocyte death can involve overlapping inflammatory and apoptotic mechanisms. MicroRNA-21 also modulates podocyte injury and apoptosis, adding another layer of regulation.
Key Genes Involved in GO:1904635 positive regulation of podocyte apoptotic process
The following genes and proteins have been experimentally linked to the positive regulation of podocyte apoptotic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RARRES1 | Secreted factor that induces podocyte apoptosis | Direct positive regulator; target for glomerular disease |
| Drp1 (DNM1L) | Mediates mitochondrial fission | Inhibition protects podocytes; target of berberine |
| ROCK1/ROCK2 | Kinases that promote cytoskeletal changes and apoptosis | Therapeutic target in glomerular and other diseases |
| Sema3A | Secreted semaphorin that sensitizes podocytes to injury | Inhibitor ameliorates doxorubicin-induced podocyte injury |
| miR-21 | MicroRNA that modulates podocyte injury and apoptosis | Potential therapeutic target in glomerular injury |
| IRF2 | Transcription factor facilitating pyroptosis | Linked to lupus nephritis podocyte death |
| APOE | Apolipoprotein E; target of Huperzine A | Potential therapeutic target in diabetic nephropathy |
| Caspase-3 | Executioner caspase | General apoptotic marker; downstream of mitochondrial dysfunction |
| Caspase-9 | Initiator caspase in apoptosome | Activated by cytochrome c release |
| Bax | Pro-apoptotic Bcl-2 family member | Promotes mitochondrial outer membrane permeabilization |
| Bak | Pro-apoptotic Bcl-2 family member | Promotes mitochondrial outer membrane permeabilization |
| Bcl-2 | Anti-apoptotic protein | Overexpression protects podocytes |
| p53 | Tumor suppressor and apoptosis regulator | Can sensitize podocytes to apoptosis |
| NF-κB | Transcription factor in inflammation and apoptosis | Modulates podocyte survival |
| TGF-β1 | Cytokine that can induce podocyte apoptosis | Profibrotic and pro-apoptotic in glomerular disease |
| Angiotensin II | Vasoactive peptide that promotes podocyte apoptosis | Target of RAAS blockade in kidney disease |
| Wnt/β-catenin | Signaling pathway in podocyte injury | Can promote apoptosis in glomerular disease |
| Notch | Developmental signaling pathway | Reactivation associated with podocyte apoptosis |
How Is positive regulation of podocyte apoptotic process Regulated?
The positive regulation of podocyte apoptotic process is controlled by a balance of pro-apoptotic and pro-survival signals. Mitochondrial dynamics, particularly Drp1-mediated fission, are regulated by post-translational modifications and interact with Bcl-2 family proteins. ROCK signaling modulates cytoskeletal changes and can be activated by Rho GTPases. MicroRNA-21 fine-tunes apoptotic gene expression. Inflammatory pathways such as IRF2 signaling can shift cell death toward pyroptosis. Therapeutic modulation of these regulators, for example with berberine or ROCK inhibitors, can protect podocytes.
positive regulation of podocyte apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RARRES1 | Diabetic nephropathy, glomerular disease progression | Podocyte-specific overexpression or knockout in mice |
| Drp1 | Diabetic nephropathy, mitochondrial dysfunction | Podocyte-specific Drp1 knockout or knockdown |
| IRF2 | Lupus nephritis, pyroptosis | IRF2 knockout or knockdown in podocytes |
| Sema3A | Doxorubicin-induced podocyte injury | Sema3A inhibitor treatment in podocyte cultures |
| APOE | Diabetic nephropathy | ApoE knockout or overexpression in podocytes |
Diabetic Nephropathy
Podocyte apoptosis is a key feature of diabetic nephropathy. Soluble RARRES1 induces podocyte apoptosis and promotes glomerular disease progression, and its levels may be elevated in diabetes. Huperzine A, targeting Apolipoprotein E, shows potential as a therapeutic drug for diabetic nephropathy based on omics analysis. Berberine protects podocytes by inhibiting Drp1-mediated mitochondrial fission, directly opposing positive regulation of apoptosis.
Lupus Nephritis
In lupus nephritis, IRF2 signaling networks facilitate podocyte pyroptosis, a form of inflammatory cell death related to apoptosis. This highlights the role of positive regulation of podocyte death in autoimmune kidney injury. Targeting IRF2 or downstream effectors may preserve podocyte viability.
Focal Segmental Glomerulosclerosis and Other Glomerular Diseases
Podocyte apoptosis contributes to the progression of focal segmental glomerulosclerosis and other glomerular diseases. Cell cycle dysregulation in podocytes is linked to glomerular disease, and apoptotic pathways intersect with these processes. MicroRNA-21 in glomerular injury further modulates podocyte survival.
From positive regulation of podocyte apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate podocyte apoptosis? | CRISPR knockout of gene X in podocytes followed by apoptosis assay |
| Does a specific point mutation in gene X alter its pro-apoptotic function? | CRISPR point mutation knock-in in podocytes |
| Does overexpression of gene X induce podocyte apoptosis? | CRISPR knock-in of a strong promoter or cDNA overexpression |
| Does tagging gene X with a fluorescent marker affect its localization during apoptosis? | CRISPR tagged knock-in in podocytes |
| Can a drug inhibit gene X-mediated podocyte apoptosis? | Pharmacological inhibition in wild-type and knockout podocytes |
| What is the transcriptional response during podocyte apoptosis? | RNA-seq of podocytes with inducible pro-apoptotic gene |
How to Study the positive regulation of podocyte apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V/PI staining | Phosphatidylserine externalization and membrane integrity | Quantify early and late apoptosis |
| TUNEL assay | DNA fragmentation | Detect apoptotic cells in tissue sections |
| Caspase-3/7 activity assay | Executioner caspase activity | Measure apoptosis induction |
| Mitochondrial fission assay | Mitochondrial morphology | Assess Drp1-mediated fission |
| RNA-seq | Global gene expression changes | Identify apoptotic pathways and regulators |
| Western blot | Protein expression and phosphorylation | Validate signaling changes |
| Co-immunoprecipitation | Protein-protein interactions | Map apoptotic complexes |
| Seahorse assay | Mitochondrial respiration | Measure metabolic dysfunction during apoptosis |
Apoptosis Assays
Annexin V/propidium iodide staining, TUNEL, and caspase-3/7 activity assays are standard for quantifying podocyte apoptosis. These methods can be applied to podocytes treated with pro-apoptotic stimuli or genetic modifications.
Mitochondrial Function Analysis
Mitochondrial fission and dysfunction can be assessed using mito-tracker staining, transmission electron microscopy, and Seahorse extracellular flux analysis. Drp1-mediated fission is a key readout.
Gene Expression Profiling
RNA-seq and quantitative PCR can identify changes in apoptotic gene expression. MicroRNA-21 and other non-coding RNAs can be profiled to understand regulatory networks.
Protein Interaction and Signaling Studies
Co-immunoprecipitation, Western blotting, and phospho-antibody arrays can dissect signaling pathways such as ROCK and IRF2 that regulate podocyte apoptosis.
How CRISPR Can Be Used to Study GO:1904635 positive regulation of podocyte apoptotic process
Knockout
CRISPR knockout of candidate positive regulators (e.g., RARRES1, Drp1) in podocytes or mouse models can test whether their loss reduces apoptosis. This is a direct way to establish causality.
Point Mutation
Introducing specific point mutations (e.g., in Drp1 GTPase domain) can dissect domain-specific functions in promoting apoptosis. This allows fine mapping of pro-apoptotic residues.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous loci enables real-time tracking of protein localization during apoptosis. Knock-in of disease-associated mutations can model human variants.
Overexpression
CRISPR-mediated overexpression (e.g., via safe-harbor locus insertion) of pro-apoptotic genes like RARRES1 can induce podocyte apoptosis and mimic disease states. This is useful for gain-of-function studies.
How EDITGENE Supports positive regulation of podocyte apoptotic process Research
Researchers studying positive regulation of podocyte apoptotic process-related genes often need to determine whether a candidate gene is causally involved in podocyte death, and whether its manipulation can protect or sensitize podocytes. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of podocyte apoptotic process research.
Frequently Asked Questions About positive regulation of podocyte apoptotic process
What is GO:1904635?
GO:1904635 is a Gene Ontology biological process term for any process that activates or increases the frequency, rate or extent of glomerular visceral epithelial cell (podocyte) apoptosis.
What genes are involved in positive regulation of podocyte apoptotic process?
Key genes include RARRES1, Drp1 (DNM1L), ROCK1/2, Sema3A, miR-21, IRF2, and APOE, among others.
How does podocyte apoptosis contribute to kidney disease?
Podocyte apoptosis leads to podocyte depletion, proteinuria, and glomerulosclerosis, driving progression of diabetic nephropathy, lupus nephritis, and other glomerular diseases.
What is the role of Drp1 in podocyte apoptosis?
Drp1 mediates mitochondrial fission, which promotes mitochondrial dysfunction and apoptosis; inhibiting Drp1 protects podocytes.
How can I study positive regulation of podocyte apoptosis in the lab?
Common methods include Annexin V/PI staining, TUNEL, caspase activity assays, RNA-seq, and CRISPR knockout or overexpression in podocyte cell lines.
What is RARRES1 and how does it induce podocyte apoptosis?
RARRES1 is a secreted protein that directly induces podocyte apoptosis and promotes glomerular disease progression.
Is there a connection between microRNA-21 and podocyte apoptosis?
Yes, microRNA-21 modulates podocyte injury and apoptosis and is a potential therapeutic target in glomerular injury.
What role does ROCK signaling play in podocyte apoptosis?
ROCK signaling promotes cytoskeletal changes and apoptosis; targeting ROCK is a therapeutic strategy in glomerular diseases.
How does IRF2 contribute to podocyte death in lupus nephritis?
IRF2 signaling networks facilitate podocyte pyroptosis, an inflammatory cell death pathway, in lupus nephritis.
Can CRISPR be used to identify new regulators of podocyte apoptosis?
Yes, CRISPR knockout and activation screens in podocytes can systematically identify positive regulators of apoptosis.
Conclusion
GO:1904635, positive regulation of podocyte apoptotic process, is a critical biological process in kidney health and disease. The integration of QuickGO definitions with verified PubMed literature reveals a complex network of secreted factors, mitochondrial dynamics, kinases, and non-coding RNAs that promote podocyte death. Targeting these regulators holds therapeutic promise for diabetic nephropathy, lupus nephritis, and other glomerular diseases. CRISPR-based models and EDITGENE services provide powerful tools to dissect these mechanisms and accelerate drug discovery.
References
- 1. Qin X et al.. 2019. Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction.. Theranostics 9(6):1698-1713 PMID: 31037132
- 2. Chen A et al.. 2020. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.. J Clin Invest 130(10):5523-5535 PMID: 32634130
- 3. Sang Y et al.. 2020. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury.. Int J Mol Sci 21(11) PMID: 32521824
- 4. Chen X et al.. 2024. Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis.. Pharmacol Res 208:107392 PMID: 39233057
- 5. Zhang F et al.. 2025. Activation of IRF2 signaling networks facilitates podocyte pyroptosis in lupus nephritis.. Biochim Biophys Acta Mol Basis Dis 1871(8):167990 PMID: 40684959
- 6. Lai JY et al.. 2015. MicroRNA-21 in glomerular injury.. J Am Soc Nephrol 26(4):805-16 PMID: 25145934
- 7. Marshall CB et al.. 2006. Cell cycle and glomerular disease: a minireview.. Nephron Exp Nephrol 102(2):e39-48 PMID: 16179806
- 8. Shahbazi R et al.. 2020. Targeting ROCK signaling in health, malignant and non-malignant diseases.. Immunol Lett 219:15-26 PMID: 31904392
